scispace - formally typeset
D

David Hellinga

Researcher at MedStar Washington Hospital Center

Publications -  34
Citations -  1087

David Hellinga is an academic researcher from MedStar Washington Hospital Center. The author has contributed to research in topics: Stent & Restenosis. The author has an hindex of 15, co-authored 31 publications receiving 1028 citations.

Papers
More filters
Journal ArticleDOI

Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries.

TL;DR: Quantitative coronary analysis indicates that percentage area stenosis and percentage diameter stenosis in magnesium alloy stent segments improved significantly at 3 months as compared to 28 days; however, reduced neointima did not result in larger lumen.
Journal ArticleDOI

Short-term effects of biocorrodible iron stents in porcine coronary arteries.

TL;DR: The current study demonstrates that stents made of biocorrodible iron are safe and in some of the measured parameters, such as intimal thickness, intimal area, and percentage occlusion, there was a trend in favor of the iron stents.
Journal ArticleDOI

PhotoPoint Photodynamic Therapy Promotes Stabilization of Atherosclerotic Plaques and Inhibits Plaque Progression

TL;DR: Photodynamic therapy simultaneously reduces plaque inflammation and promotes repopulation of plaques with a SMC-rich stable plaque cell phenotype while reducing disease progression, suggesting that PDT is a promising therapy for the treatment of acute coronary syndromes.
Journal ArticleDOI

Oral rapamycin inhibits growth of atherosclerotic plaque in apoE knock-out mice

TL;DR: Oral rapamycin is effective in attenuating the progression of atherosclerotic plaque in the mice and appears to reduce neointima formation when coated on stents.